NY State Senate Bill 2017-S3570A

Archive: Last Bill Status - Stricken

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 29, 2018	recommit, enacting clause stricken
Jan 03, 2018	referred to health
Jun 08, 2017	print number 3570b
Jun 08, 2017	amend and recommit to higher education
Apr 26, 2017	print number 3570a
Apr 26, 2017	amend and recommit to higher education
Mar 13, 2017	reported and committed to higher education
Jan 24, 2017	referred to health

Votes

- Mar 14, 2017 - Health Committee Vote
  S3570A
  
  10
  
  Aye
  
  0
  
  Nay
  
  7
  
  Aye with Reservations
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  - - Health Committee Vote: Mar 14, 2017
      
      aye (10)
      
      Felder
      
      Golden
      
      Hannon
      
      Jacobs
      
      Larkin
      
      Little
      
      Ritchie
      
      Seward
      
      Tedisco
      
      Valesky
      
      aye wr (7)
      
      Hoylman-Sigal
      
      Kaminsky
      
      Montgomery
      
      Murphy
      
      Persaud
      
      Rivera
      
      Stavisky

Bill Amendments

Original

B (Active)

co-Sponsors

2017-S3570 - Details

See Assembly Version of this Bill:: A5963
Law Section:: Public Health Law
Laws Affected:: Amd §§3501 & 3502, Pub Health L

2017-S3570 - Summary

Relates to procedures performed by cardiovascular technologists.

2017-S3570 - Sponsor Memo

                                 BILL NUMBER:  S3570

 TITLE OF BILL :  An act to amend the public health law, in relation
to cardiovascular technologists

 PURPOSE :

Authorize Cardiovascular Technologists (CVTs) to administer contrast
materials during cardiovascular interventional procedures, under the
direct supervision of a physician.

 SUMMARY OF PROVISIONS :

Section 1 defines a cardiovascular technologist

Section 2 authorizes the cardiovascular technologist to administer the
contrast materials during cardiovascular interventional procedures
under the direct supervision of a physician.

Section 3 provides that the bill would take effect immediately

 EXISTING LAW :

Under current law, the contract materials must be administered by
physicians.

 JUSTIFICATION :

Contrast materials are used to improve images produced by x-rays,
computed tomography (CT), magnetic resonance (MR) imaging, and
ultrasound. For cardio-vascular procedures the most common contrast
material is a non-ionic radiopaque contrast medium, which is used to
enhance fluoroscopy or cineradiography (moving x-rays). It is
introduced into a patient's artery by inserting a syringe with the
contrast material into a line placed by the physician. When
administered in this manner during a cardiovascular procedure, the
contrast material allows the physician to locate and visualize the
targeted sites in real time. These contrast materials are safe drugs;
mild adverse reactions can occur but are uncommon and treatable.

CVTs assist in technical procedures for cardiac catheterizations and
interventions. Their tasks include patient preparation, assisting
physicians, hemodynamic monitoring, vascular access site management
and first assistant. They must also accurately complete required
documentation for procedures. Their work during cardiovascular
interventions is strictly under a physician's direct supervision.
While CVTs may possess a certification in their field from a college
program, there is no license or certification requirement to be a CVT;
rather, hospitals ensure that CVTs have the knowledge, training and
competency to perform these tasks. CVTs are willing and fully able to
administer contrast materials to patients during cardiovascular
interventional procedures, under the supervision of a physician.

In New York, CVTs are not permitted to administer contrast materials.
The NYS Nurse Practice Act defines the scope of nursing practice and
prohibits others who do not have a nursing license or other relevant
license from engaging in the practice of nursing. In 2006, the Office
of the Professions of the NYS State Education Department issued a
"Practice Alert and Guidelines" that warned against the administration
of medications by unlicensed persons. This prohibition would include
the administration of contrast materials by CVTs. Based on this
ruling, the Department of Health has taken action against hospitals
that have permitted CVTs to administer contrast materials.

The administration of contrast materials by a CVT under the
supervision of a physician raises no significant safety issue. The
medication itself is quite safe. And the setting provides optimal
oversight - during a cardiovascular procedure a physician, nurse, and
other health care professionals are present and monitoring the
procedure. It is a highly controlled environment. In fact, empowering
CVTs to perform this function will improve patient safety by
eliminating the distraction caused when a physician or nurse is pulled
away from more pressing tasks to administer contrast material.  The
use of CVTs is also inherently more cost effective than reliance upon
physicians or nurses for this function.

 LEGISLATIVE HISTORY :

New Bill

 FISCAL IMPLICATIONS :

To be determined

 EFFECTIVE DATE :
This Act shall take effect immediately

2017-S3570 - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   3570
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                             January 24, 2017
                                ___________
 
 Introduced  by  Sen. VALESKY -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law,  in  relation  to  cardiovascular
   technologists
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. Section 3501 of the public health law is amended by  adding
 a new subdivision 20 to read as follows:
   20.  "CARDIOVASCULAR TECHNOLOGIST" MEANS A PERSON WHO IS AUTHORIZED TO
 ASSIST WITH DIAGNOSTIC EXAMINATIONS AND THERAPEUTIC INTERVENTIONS OF THE
 HEART AND BLOOD VESSELS UNDER THE DIRECT  SUPERVISION  OF  A  PHYSICIAN,
 INCLUDING   INVASIVE  CARDIOLOGY-CARDIAC  CATHETERIZATION,  NON-INVASIVE
 CARDIOLOGY, NON-INVASIVE PERIPHERAL VASCULAR STUDY, AND CARDIAC ELECTRO-
 PHYSIOLOGY.
   § 2. The opening paragraph of subdivision 4 of  section  3502  of  the
 public health law is designated paragraph (a) and a new paragraph (b) is
 added to read as follows:
   (B)  NOTHING  IN  THIS  ARTICLE OR IN ANY OTHER PROVISION OF LAW SHALL
 PREVENT A CARDIOVASCULAR TECHNOLOGIST, ACTING UNDER  THE  DIRECT  SUPER-
 VISION  OF  A  PHYSICIAN,  FROM INTRODUCING CONTRAST MEDIUM TO A PATIENT
 DURING A CARDIOVASCULAR DIAGNOSTIC OR INTERVENTIONAL  PROCEDURE  THROUGH
 AN  ARTERIAL LINE PLACED BY A LICENSED PRACTITIONER. THE INTRODUCTION OF
 CONTRAST MEDIUM IN PREPARATION OF OR DURING SUCH  PROCEDURES  SHALL  NOT
 CONSTITUTE  THE  ADMINISTRATION  OF  MEDICATION FOR THE PURPOSES OF THIS
 SECTION.
   § 3. This act shall take effect immediately.
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD09035-01-7

co-Sponsors

2017-S3570A - Details

See Assembly Version of this Bill:: A5963
Law Section:: Public Health Law
Laws Affected:: Amd §§3501 & 3502, Pub Health L

2017-S3570A - Summary

Relates to procedures performed by cardiovascular technologists.

2017-S3570A - Sponsor Memo

                                 BILL NUMBER:  S3570A

 TITLE OF BILL :

An act to amend the public health law, in relation to cardiovascular
technologists

 PURPOSE :

Authorize Cardiovascular Technologists (CVTs) to administer contrast
materials during cardiovascular interventional procedures, under the
direct supervision of a physician.

 SUMMARY OF PROVISIONS :

Section 1 defines a cardiovascular technologist

Section 2 authorizes the cardiovascular technologist to administer the
contrast materials during cardiovascular interventional procedures
under the direct supervision of a physician.

Section 3 provides that the bill would take effect immediately

 EXISTING LAW :

Under current law, the contract materials must be administered by

physicians.

 JUSTIFICATION :

Contrast materials are used to improve images produced by x-rays,
computed tomography (CT), magnetic resonance (MR) imaging, and
ultrasound. For cardio-vascular procedures the most common contrast
material is a non-ionic radiopaque contrast medium, which is used to
enhance fluoroscopy or cineradiography (moving x-rays). It is
introduced into a patient's artery by inserting a syringe with the
contrast material into a line placed by the physician. When
administered in this manner during a cardiovascular procedure, the
contrast material allows the physician to locate and visualize the
targeted sites in real time. These contrast materials are safe drugs;
mild adverse reactions can occur but are uncommon and treatable.

CVTs assist in technical procedures for cardiac catheterizations and
interventions. Their tasks include patient preparation, assisting
physicians, hemodynamic monitoring, vascular access site management
and first assistant. They must also accurately complete required
documentation for procedures. Their work during cardiovascular
interventions is strictly under a physician's direct supervision.
While CVTs may possess a certification in their field from a college
program, there is no license or certification requirement to be a CVT;
rather, hospitals ensure that CVTs have the knowledge, training and
competency to perform these tasks. CVTs are willing and fully able to
administer contrast materials to patients during cardiovascular
interventional procedures, under the supervision of a physician.

In New York, CVTs are not permitted to administer contrast materials.
The NYS Nurse Practice Act defines the scope of nursing practice and
prohibits others who do not have a nursing license or other relevant
license from engaging in the practice of nursing. In 2006, the Office
of the Professions of the NYS State Education Department issued a
"Practice Alert and Guidelines" that warned against the administration
of medications by unlicensed persons. This prohibition would include
the administration of contrast materials by CVTs. Based on this
ruling, the Department of Health has taken action against hospitals
that have permitted CVTs to administer contrast materials.

The administration of contrast materials by a CVT under the
supervision of a physician raises no significant safety issue. The
medication itself is quite safe. And the setting provides optimal
oversight - during a cardiovascular procedure a physician, nurse, and
other health care professionals are present and monitoring the
procedure. It is a highly controlled environment. In fact, empowering
CVTs to perform this function will improve patient safety by
eliminating the distraction caused when a physician or nurse is pulled
away from more pressing tasks to administer contrast material.  The
use of CVTs is also inherently more cost effective than reliance upon
physicians or nurses for this function.

 LEGISLATIVE HISTORY :

New Bill

 FISCAL IMPLICATIONS :

To be determined

 EFFECTIVE DATE :
This Act shall take effect immediately

2017-S3570A - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  3570--A
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                             January 24, 2017
                                ___________
 
 Introduced  by  Sens. VALESKY, LITTLE -- read twice and ordered printed,
   and when printed to  be  committed  to  the  Committee  on  Health  --
   reported  favorably from said committee and committed to the Committee
   on Higher Education -- committee  discharged,  bill  amended,  ordered
   reprinted as amended and recommitted to said committee

 AN  ACT  to  amend  the public health law, in relation to cardiovascular
   technologists
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Section 3501 of the public health law is amended by adding
 a new subdivision 20 to read as follows:
   20. "CARDIOVASCULAR TECHNOLOGIST" MEANS A PERSON WHO IS AUTHORIZED  TO
 ASSIST WITH DIAGNOSTIC EXAMINATIONS AND THERAPEUTIC INTERVENTIONS OF THE
 HEART  AND  BLOOD VESSELS UNDER THE PERSONAL SUPERVISION OF A PHYSICIAN,
 INCLUDING  INVASIVE  CARDIOLOGY-CARDIAC  CATHETERIZATION,   NON-INVASIVE
 CARDIOLOGY, NON-INVASIVE PERIPHERAL VASCULAR STUDY, AND CARDIAC ELECTRO-
 PHYSIOLOGY.
   §  2.  The  opening  paragraph of subdivision 4 of section 3502 of the
 public health law is designated paragraph (a) and a new paragraph (b) is
 added to read as follows:
   (B) NOTHING IN THIS ARTICLE OR IN ANY OTHER  PROVISION  OF  LAW  SHALL
 PREVENT  A CARDIOVASCULAR TECHNOLOGIST, ACTING UNDER THE PERSONAL SUPER-
 VISION OF A PHYSICIAN, FROM INTRODUCING CONTRAST  MEDIUM  TO  A  PATIENT
 DURING  A  CARDIOVASCULAR DIAGNOSTIC OR INTERVENTIONAL PROCEDURE THROUGH
 AN ARTERIAL LINE PLACED BY A LICENSED PRACTITIONER. THE INTRODUCTION  OF
 CONTRAST  MEDIUM  IN  PREPARATION OF OR DURING SUCH PROCEDURES SHALL NOT
 CONSTITUTE THE ADMINISTRATION OF MEDICATION FOR  THE  PURPOSES  OF  THIS
 SECTION.
   § 3. This act shall take effect immediately.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD09035-02-7

co-Sponsors

2017-S3570B (ACTIVE) - Details

See Assembly Version of this Bill:: A5963
Law Section:: Public Health Law
Laws Affected:: Amd §§3501 & 3502, Pub Health L

2017-S3570B (ACTIVE) - Summary

Relates to procedures performed by cardiovascular technologists.

2017-S3570B (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S3570B

 TITLE OF BILL :

An act to amend the public health law, in relation to cardiovascular
technologists

 PURPOSE :

Authorize Cardiovascular Technologists (CVTs) to administer contrast
materials during cardiovascular interventional procedures, under the
direct supervision of a physician.

 SUMMARY OF PROVISIONS :

Section 1 defines a cardiovascular technologist

Section 2 authorizes the cardiovascular technologist to administer the
contrast materials during cardiovascular interventional procedures
under the direct supervision of a physician.

Section 3 provides that the bill would take effect immediately

 EXISTING LAW :

Under current law, the contract materials must be administered by

physicians.

 JUSTIFICATION :

Contrast materials are used to improve images produced by x-rays,
computed tomography (CT), magnetic resonance (MR) imaging, and
ultrasound. For cardio-vascular procedures the most common contrast
material is a non-ionic radiopaque contrast medium, which is used to
enhance fluoroscopy or cineradiography (moving x-rays). It is
introduced into a patient's artery by inserting a syringe with the
contrast material into a line placed by the physician. When
administered in this manner during a cardiovascular procedure, the
contrast material allows the physician to locate and visualize the
targeted sites in real time. These contrast materials are safe drugs;
mild adverse reactions can occur but are uncommon and treatable.

CVTs assist in technical procedures for cardiac catheterizations and
interventions. Their tasks include patient preparation, assisting
physicians, hemodynamic monitoring, vascular access site management
and first assistant. They must also accurately complete required
documentation for procedures. Their work during cardiovascular
interventions is strictly under a physician's direct supervision.
While CVTs may possess a certification in their field from a college
program, there is no license or certification requirement to be a CVT;
rather, hospitals ensure that CVTs have the knowledge, training and
competency to perform these tasks. CVTs are willing and fully able to
administer contrast materials to patients during cardiovascular
interventional procedures, under the supervision of a physician.

In New York, CVTs are not permitted to administer contrast materials.
The NYS Nurse Practice Act defines the scope of nursing practice and
prohibits others who do not have a nursing license or other relevant
license from engaging in the practice of nursing. In 2006, the Office
of the Professions of the NYS State Education Department issued a
"Practice Alert and Guidelines" that warned against the administration
of medications by unlicensed persons. This prohibition would include
the administration of contrast materials by CVTs. Based on this
ruling, the Department of Health has taken action against hospitals
that have permitted CVTs to administer contrast materials.

The administration of contrast materials by a CVT under the
supervision of a physician raises no significant safety issue. The
medication itself is quite safe. And the setting provides optimal
oversight - during a cardiovascular procedure a physician, nurse, and
other health care professionals are present and monitoring the
procedure. It is a highly controlled environment. In fact, empowering
CVTs to perform this function will improve patient safety by
eliminating the distraction caused when a physician or nurse is pulled
away from more pressing tasks to administer contrast material.  The
use of CVTs is also inherently more cost effective than reliance upon
physicians or nurses for this function.

 LEGISLATIVE HISTORY :

New Bill

 FISCAL IMPLICATIONS :

To be determined

 EFFECTIVE DATE :
This Act shall take effect immediately

2017-S3570B (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  3570--B
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                             January 24, 2017
                                ___________
 
 Introduced  by  Sens. VALESKY, LITTLE -- read twice and ordered printed,
   and when printed to  be  committed  to  the  Committee  on  Health  --
   reported  favorably from said committee and committed to the Committee
   on Higher Education -- committee  discharged,  bill  amended,  ordered
   reprinted  as  amended  and recommitted to said committee -- committee
   discharged, bill amended, ordered reprinted as amended and recommitted
   to said committee
 
 AN ACT to amend the public health law,  in  relation  to  cardiovascular
   technologists
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 4 of section 3502 of the public health law,  as
 amended  by  chapter  175  of  the  laws  of 2006, is amended to read as
 follows:
   4. (A) No radiologic technologist shall administer or inject  intrave-
 nous  contrast media unless [(a)] (I) the individual is certified by the
 department to perform such function in accordance with  the  commission-
 er's  rules  and regulations [(b)] (II) such administration or injection
 has been approved by a physician, physician's assistant,  nurse  practi-
 tioner  or  registered professional nurse within twenty-four hours prior
 to the administration or injection [(c)] (III) a physician,  physician's
 assistant,  nurse practitioner or registered professional nurse performs
 an evaluation of the patient on the day of the procedure. Administration
 or injection of contrast media means and is limited to the placement  or
 insertion  of  a  needle  or  a  catheter, not exceeding three inches in
 length and not above the level of  the  axilla  into  a  person's  upper
 extremity  and  the  administration  or  injection  of  the  intravenous
 contrast media, manually or by mechanical injector, but  does  not  mean
 the  determination  of the type or volume of media to be administered or
 injected.

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD09035-05-7

 S. 3570--B                          2
 
   (B) NOTHING IN THIS ARTICLE OR IN ANY OTHER  PROVISION  OF  LAW  SHALL
 PREVENT  A CARDIOVASCULAR TECHNOLOGIST, ACTING UNDER THE PERSONAL SUPER-
 VISION OF A PHYSICIAN, FROM INTRODUCING CONTRAST  MEDIUM  TO  A  PATIENT
 DURING  A  CARDIOVASCULAR DIAGNOSTIC OR INTERVENTIONAL PROCEDURE THROUGH
 AN  ARTERIAL LINE PLACED BY A LICENSED PRACTITIONER. THE INTRODUCTION OF
 CONTRAST MEDIUM IN PREPARATION OF OR DURING SUCH  PROCEDURES  SHALL  NOT
 CONSTITUTE  THE  ADMINISTRATION  OF  MEDICATION FOR THE PURPOSES OF THIS
 SECTION.
   § 2. This act shall take effect immediately.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S3570A

Sponsored By

Archive: Last Bill Status - Stricken

Mar 14, 2017 - Health Committee Vote

Health Committee Vote: Mar 14, 2017

Bill Amendments

co-Sponsors

2017-S3570 - Details

2017-S3570 - Summary

2017-S3570 - Sponsor Memo

2017-S3570 - Bill Text download pdf

co-Sponsors

2017-S3570A - Details

2017-S3570A - Summary

2017-S3570A - Sponsor Memo

2017-S3570A - Bill Text download pdf

co-Sponsors

2017-S3570B (ACTIVE) - Details

2017-S3570B (ACTIVE) - Summary

2017-S3570B (ACTIVE) - Sponsor Memo

2017-S3570B (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S3570A

Share this bill

Sponsored By

David J. Valesky

Archive: Last Bill Status - Stricken

Bill Amendments

co-Sponsors

Betty Little

2017-S3570 - Details

2017-S3570 - Summary

2017-S3570 - Sponsor Memo

2017-S3570 - Bill Text download pdf

co-Sponsors

Betty Little

2017-S3570A - Details

2017-S3570A - Summary

2017-S3570A - Sponsor Memo

2017-S3570A - Bill Text download pdf

co-Sponsors

Betty Little

2017-S3570B (ACTIVE) - Details

2017-S3570B (ACTIVE) - Summary

2017-S3570B (ACTIVE) - Sponsor Memo

2017-S3570B (ACTIVE) - Bill Text download pdf

Comments